Methyl (S)-3-((1r*,3R*)-3-((1H-indol-3-yl)methyl)cyclobutane-1-carboxamido)-2-(phenylsulfonamido)propanoate
Molbank · 01.07.2026 · 2026 (4) · M2194
DOI: 10.3390/m2194 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molbank, online erschienen am 01.07.2026. Verfasst von Helen M. Sheldrake. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EPSRC.
Abstract (Originalsprache)
The cyclobutane ring has attractive properties as a scaffold in medicinal chemistry but is underused, potentially due to the limited methods available for synthesising highly functionalised cyclobutanes. This short note describes the synthesis of the 1,3-cis disubstituted cyclobutane, methyl (S)-3-((1r*,3R*)-3-((1H-indol-3-yl)methyl)cyclobutane-1-carboxamido)-2-(phenylsulfonamido)propanoate using a one-pot thermal stepwise cycloaddition reaction and its characterisation by NMR spectroscopy and HRMS.
Förderung
- EPSRC
Zitieren
APA
Sheldrake, H. M. (2026). Methyl (S)-3-((1r*,3R*)-3-((1H-indol-3-yl)methyl)cyclobutane-1-carboxamido)-2-(phenylsulfonamido)propanoate. Molbank, 2026(4), M2194. https://doi.org/10.3390/m2194
Vancouver
Sheldrake HM. Methyl (S)-3-((1r*,3R*)-3-((1H-indol-3-yl)methyl)cyclobutane-1-carboxamido)-2-(phenylsulfonamido)propanoate. Molbank. 2026;2026(4):M2194. doi:10.3390/m2194
BibTeX
@article{Sheldrake2026,
author = {Sheldrake, Helen M.},
title = {Methyl (S)-3-((1r*,3R*)-3-((1H-indol-3-yl)methyl)cyclobutane-1-carboxamido)-2-(phenylsulfonamido)propanoate},
journal = {Molbank},
year = {2026},
volume = {2026},
number = {4},
pages = {M2194},
doi = {10.3390/m2194}
}
EUVIMED